Gamma Investing LLC Enanta Pharmaceuticals Inc Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Gamma Investing LLC holds 43 shares of ENTA stock, worth $432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 43
-0.0%
Holding current value
$432
Previous $751,000
25.7%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ENTA
# of Institutions
99Shares Held
21.2MCall Options Held
10.4KPut Options Held
2.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$21.1 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$19.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$18.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.46MShares$14.6 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.25MShares$12.6 Million7.45% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $208M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...